These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30954405)
1. The impact of postoperative inflammatory biomarkers on oncologic outcomes of bladder cancer. Albisinni S; Moussa I; Aoun F; Quackels T; Assenmacher G; Peltier A; Roumeguère T Prog Urol; 2019 Apr; 29(5):270-281. PubMed ID: 30954405 [TBL] [Abstract][Full Text] [Related]
2. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer. Cantiello F; Russo GI; Vartolomei MD; Farhan ARA; Terracciano D; Musi G; Lucarelli G; Di Stasi SM; Hurle R; Serretta V; Busetto GM; Scafuro C; Perdonà S; Borghesi M; Schiavina R; Cioffi A; De Berardinis E; Almeida GL; Bove P; Lima E; Ucciero G; Matei DV; Crisan N; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Mirone V; Shariat SF; Ferro M Eur Urol Oncol; 2018 Oct; 1(5):403-410. PubMed ID: 31158079 [TBL] [Abstract][Full Text] [Related]
3. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy. Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651 [TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452 [TBL] [Abstract][Full Text] [Related]
5. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. D'Andrea D; Moschini M; Gust KM; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF J Surg Oncol; 2017 Mar; 115(4):455-461. PubMed ID: 28105663 [TBL] [Abstract][Full Text] [Related]
6. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes. Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy. Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414 [TBL] [Abstract][Full Text] [Related]
9. The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Ann Surg Oncol; 2016 Jan; 23(1):335-42. PubMed ID: 26152275 [TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy. Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K Urol Oncol; 2016 Jun; 34(6):257.e11-7. PubMed ID: 27038696 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer. Zhang J; Zhou X; Ding H; Wang L; Liu S; Liu Y; Chen Z BMC Urol; 2020 Mar; 20(1):31. PubMed ID: 32192483 [TBL] [Abstract][Full Text] [Related]
12. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy? Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942 [TBL] [Abstract][Full Text] [Related]
13. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up. Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587 [TBL] [Abstract][Full Text] [Related]
14. Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy. Klemm J; Shariat SF; Laukhtina E; Rajwa P; Vetterlein MW; Schuettfort VM; von Deimling M; Dahlem R; Fisch M; Rink M Clin Genitourin Cancer; 2024 Jun; 22(3):102079. PubMed ID: 38614853 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer. Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816 [TBL] [Abstract][Full Text] [Related]
16. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy. Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608 [TBL] [Abstract][Full Text] [Related]
17. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819 [TBL] [Abstract][Full Text] [Related]
18. Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Laukhtina E; Schuettfort VM; D'Andrea D; Pradere B; Mori K; Quhal F; Sari Motlagh R; Mostafaei H; Katayama S; Grossmann NС; Rajwa P; Zeinler F; Abufaraj M; Moschini M; Zimmermann K; Karakiewicz PI; Fajkovic H; Scherr D; Compérat E; Nyirady P; Rink M; Enikeev D; Shariat SF Mol Carcinog; 2022 Jan; 61(1):5-18. PubMed ID: 34587660 [TBL] [Abstract][Full Text] [Related]
19. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches. Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy. Schuettfort VM; Pradere B; D'Andrea D; Grossmann NC; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Karakiewicz PI; Motlagh RS; Katayama S; Lotan Y; Scherr D; Abufaraj M; Fajkovica H; Compérat E; Enikeev D; Shariat SF J Urol; 2021 Nov; 206(5):1122-1131. PubMed ID: 34181469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]